N-α-Z-N-ε-Boc-D-lysine is a protected lysine derivative in which the α-amino group is carbobenzyloxy (Z/Cbz) protected and the ε-amino group is tert-butoxycarbonyl (Boc) protected, while the side chain retains the characteristic (CH2)4 amine-bearing lysine skeleton. The molecule contains a free carboxylic acid functional group and a D-stereochemical configuration at the α-carbon as indicated by the product name, with two orthogonally protected amino functionalities that can be unmasked selectively under appropriate deprotection conditions. It is employed as a stepwise building block for peptide synthesis and related amide bond formation, enabling controlled incorporation of lysine residues with orthogonally removable protecting groups for sequential coupling and chemoselective derivatization.
CAT No: CP01455
CAS No:66845-42-9
Synonyms/Alias:Z-D-Lys(Boc)-OH;66845-42-9;Z-Lys(Boc)-OH;CBZ-D-LYS(BOC)-OH;Nalpha-Z-Nepsilon-Boc-D-lysine;Nalpha-Cbz-Nepsilon-Boc-D-Lysine;N-Benzyloxycarbonyl-N'-(tert-Butoxycarbonyl)-L-lysine;AmbotzZAA1151;PubChem12957;AC1OJJ8V;N|A-Z-N|A-Boc-D-lysine;96019_ALDRICH;N|A-Cbz-N|A-Boc-D-Lysine;Cbz-D-Lys(Boc)-OH.DCHA;SCHEMBL2467817;96019_FLUKA;MolPort-003-939-913;ACT03124;ZINC4521932;CZ-075;AKOS015841476;AJ-51476;AK-46019;BR-46019;SC-09719
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.